|
⚲
|
| Keyboard |
| Symetryx Corp
✚
|
|
|---|---|
| CIK # | 0001991925 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001991925] | |
| 4 | [0001991925] | |
| 5 | [0001991925] | |
| SC 13D | [0001991925] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Symetryx Corp | Check-Cap Ltd | [2023-09-29] |
| Symetryx Corp | Neubase Therapeutics Inc | [2023-08-31] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ohr Pharmaceutical Inc | |
| Shiff Barry | |
| Symetryx Corp | |
| Shiff Aleta |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ohr Pharmaceutical Inc NBSE
Common Stock, par value $0.0001
|
2023-09-18 | Other | 0 | $0.00 | |
|
Ohr Pharmaceutical Inc NBSE
Common Stock, Par Value $0.0001 per Share
|
2023-09-18 | Sell | 50,000 | $1.19 | 59,500 |
|
Ohr Pharmaceutical Inc NBSE
Common Stock, Par Value $0.0001 per Share
|
2023-09-15 | Sell | 103,337 | $1.26 | 130,205 |
|
Ohr Pharmaceutical Inc NBSE
Common Stock, Par Value $0.0001 per Share
|
2023-09-14 | Sell | 129,108 | $1.44 | 185,916 |
|
Ohr Pharmaceutical Inc NBSE
Common Stock, Par Value $0.0001 per Share
|
2023-09-11 | Sell | 3,376 | $1.44 | 4,861 |
|
Ohr Pharmaceutical Inc NBSE
Common Stock, Par Value $0.0001 per Share
|
2023-09-08 | Sell | 128,847 | $1.53 | 197,136 |
|
Ohr Pharmaceutical Inc NBSE
Common Stock, Par Value $0.0001 per Share
|
2023-09-07 | Sell | 74,852 | $1.80 | 134,734 |
|
Ohr Pharmaceutical Inc NBSE
Common Stock, Par Value $0.0001 per Share
|
2023-09-01 | Buy | 61,076 | $0.98 | 59,854 |